Search Result

Results for "

TP53

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Apoptosis (14) Autophagy (5) Casein Kinase (1) CDK (1) Deubiquitinase (2) DNA/RNA Synthesis (2) E1/E2/E3 Enzyme (3) Ferroptosis (5) Interleukin Related (1) Ligands for E3 Ligase (2) MDM-2/p53 (16) MHC (1) Molecular Glues (2) mRNA (1) mTOR (1) PI3K (2) Polo-like Kinase (PLK) (1) Reactive Oxygen Species (ROS) (1) Reference Standards (1) Small Interfering RNA (siRNA) (14) β-catenin (2)
By Research Areas:	Cancer (27) Endocrinology (1) Inflammation/Immunology (1)
Oligonucleotides:	Rat Pre-designed siRNA Sets (3) mRNA (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (10) siRNAs (14)

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Recombinant Proteins

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P11089

TP53 neoepitope	MHC	Cancer
TP53 neoepitope is a high-affinity antigenic peptide targeting HLA-A. TP53 neoepitope can triggers CD8 ⁺ T cell-mediated killing of TP53-mutant tumor cells. TP53 neoepitope is promising for research of solid tumors harboring TP53 hotspot mutations (e.g., R175H, R273H) .

HY-RS14913

Tp53 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Tp53 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tp53 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tp53 Rat Pre-designed siRNA Set A Tp53 Rat Pre-designed siRNA Set A

HY-RS14912

TP53 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TP53 Human Pre-designed siRNA Set A contains three designed siRNAs for TP53 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TP53 Human Pre-designed siRNA Set A TP53 Human Pre-designed siRNA Set A

HY-RS14922

TP53RK Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TP53RK Human Pre-designed siRNA Set A contains three designed siRNAs for TP53RK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TP53RK Human Pre-designed siRNA Set A TP53RK Human Pre-designed siRNA Set A

HY-RS14915

TP53BP1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TP53BP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TP53BP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TP53BP1 Human Pre-designed siRNA Set A TP53BP1 Human Pre-designed siRNA Set A

HY-RS26028

Tp53i3 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Tp53i3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tp53i3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tp53i3 Rat Pre-designed siRNA Set A Tp53i3 Rat Pre-designed siRNA Set A

HY-RS14920

TP53INP1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TP53INP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TP53INP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TP53INP1 Human Pre-designed siRNA Set A TP53INP1 Human Pre-designed siRNA Set A

HY-RS14917

TP53I11 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TP53I11 Human Pre-designed siRNA Set A contains three designed siRNAs for TP53I11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TP53I11 Human Pre-designed siRNA Set A TP53I11 Human Pre-designed siRNA Set A

HY-RS28596

Tp53inp1 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Tp53inp1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tp53inp1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tp53inp1 Rat Pre-designed siRNA Set A Tp53inp1 Rat Pre-designed siRNA Set A

HY-RS14916

TP53BP2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TP53BP2 Human Pre-designed siRNA Set A contains three designed siRNAs for TP53BP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TP53BP2 Human Pre-designed siRNA Set A TP53BP2 Human Pre-designed siRNA Set A

HY-RS14918

TP53I13 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TP53I13 Human Pre-designed siRNA Set A contains three designed siRNAs for TP53I13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TP53I13 Human Pre-designed siRNA Set A TP53I13 Human Pre-designed siRNA Set A

HY-RS14919

TP53I3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TP53I3 Human Pre-designed siRNA Set A contains three designed siRNAs for TP53I3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TP53I3 Human Pre-designed siRNA Set A TP53I3 Human Pre-designed siRNA Set A

HY-RS14921

TP53INP2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TP53INP2 Human Pre-designed siRNA Set A contains three designed siRNAs for TP53INP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TP53INP2 Human Pre-designed siRNA Set A TP53INP2 Human Pre-designed siRNA Set A

HY-RS14914

TP53AIP1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TP53AIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TP53AIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TP53AIP1 Human Pre-designed siRNA Set A TP53AIP1 Human Pre-designed siRNA Set A

HY-174511

*Human TP53* mRNA**	mRNA	Cancer
Human TP53 mRNA encodes the human tumor protein p53 (TP53) protein, a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. TP53 responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism.

HY-171499

Cenersen EL625	MDM-2/p53	Cancer
Cenersen (EL625) is an oligonucleotide targeting *TP53. Cenersen can eliminate the activity of TP53* gain-of-function mutants and increase the sensitivity of lymphoma cells to cytotoxic chemotherapy in vitro. Cenersen can be used for the study of chronic lymphocytic leukemia (CLL) .

HY-W013053

Dibenz[a,h]anthracene DBA; 1,2,5,6-Dibenzanthracene; Benzo[k]tetraphene	DNA/RNA Synthesis Apoptosis MDM-2/p53	Cancer
Dibenz[a,h]anthracene (DBA) is a polycyclic aromatic hydrocarbon (PAH) of considerable tumorigenicity. Dibenz[a,h]anthracene results in DNA adduct formation leading to the activation of a DNA damage response. Dibenz[a,h]anthracene induces cell cycle arrest and apoptosis via both Tp53-dependent and Tp53-independent mechanisms .

HY-W013053R

Dibenz[a,h]anthracene (Standard) DBA (Standard); 1,2,5,6-Dibenzanthracene (Standard); Benzo[k]tetraphene (Standard)	DNA/RNA Synthesis Apoptosis Reference Standards MDM-2/p53	Cancer
Dibenz[a,h]anthracene (Standard) is the analytical standard of Dibenz[a,h]anthracene. This product is intended for research and analytical applications. Dibenz[a,h]anthracene (DBA) is a polycyclic aromatic hydrocarbon (PAH) of considerable tumorigenicity. Dibenz[a,h]anthracene results in DNA adduct formation leading to the activation of a DNA damage response. Dibenz[a,h]anthracene induces cell cycle arrest and apoptosis via both Tp53-dependent and Tp53-independent mechanisms .

HY-16271

Kevetrin hydrochloride 2 Publications Verification 4-Isothioureidobutyronitrile hydrochloride; thioureidobutyronitrile hydrochloride; thioureido butyronitrile hydrochloride	MDM-2/p53 Apoptosis	Cancer
Kevetrin hydrochloride is a potent activator of *p53, induces apoptosis in TP53* wild-type and mutant acute myeloid leukemia cells. Kevetrin a preferential cytotoxic activity against blast cells .

HY-156633

Rezatapopt PC14586	MDM-2/p53	Cancer
Rezatapopt (PC14586) is an orally active antineoplastic agent. Rezatapopt binds to a pocket created by the TP53 Y220C mutation. Rezatapopt restores p53 tumor suppressor functions by stabilization of the p53 protein structure. Rezatapopt demonstrates tumor inhibition and regression in mouse models with established human tumor xenografts harboring the TP53 Y220C mutation .

HY-175000

L14-8	Ferroptosis Polo-like Kinase (PLK) MDM-2/p53	Endocrinology Cancer
L14-8 is a potent ferroptosis inducer. L14-8 promotes PLK1 degradation via ubiquitination, increasing TP53 phosphorylation to enhance SAT1 transcription, thereby triggering ferroptosis and cancer cell death. L14-8 can be used for the study of advanced prostate cancer .

HY-19980A

PRIMA-1 2 Publications Verification NSC-281668	Autophagy MDM-2/p53 Ferroptosis Apoptosis	Cancer
PRIMA-1 (NSC-281668) is a mutant *p53* reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A.

HY-19980

Eprenetapopt 10+ Cited Publications APR-246; PRIMA-1Met	MDM-2/p53 Autophagy Apoptosis Ferroptosis	Cancer
Eprenetapopt (APR-246) is a first-in-class, small molecule that restores wild-type p53 functions in TP53-mutant cells. Eprenetapopt triggers apoptosis in tumor cells. Eprenetapopt also targets the selenoprotein thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance .

HY-19980G

Eprenetapopt APR-246; PRIMA-1Met	MDM-2/p53 Apoptosis Ferroptosis	Cancer
Eprenetapopt (GMP) (APR-246(GMP)) is Eprenetapopt (HY-19980) in GMP grade. Eprenetapopt (APR-246) is a first-in-class, small molecule that restores wild-type p53 functions in TP53-mutant cells. Eprenetapopt triggers apoptosis in tumor cells. Eprenetapopt also targets the selenoprotein thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance .

HY-10029A

(Rac)-Nutlin-3 (Rac)-Rebemadlin	MDM-2/p53 Autophagy Apoptosis E1/E2/E3 Enzyme	Cancer
(Rac)-Nutlin-3 (Rebemadlin), an active enantiomer of Nutlin-3, is a potent murine double minute (MDM2) inhibitor (IC₅₀=90 nM). (Rac)-Nutlin-3 inhibits *MDM2-p53* interactions and stabilizes the p53 protein, and induces cell autophagy and apoptosis. (Rac)-Nutlin-3 has the potential for the study of TP53 wild-type ovarian carcinomas .

HY-100765

BI-0252	MDM-2/p53 E1/E2/E3 Enzyme	Cancer
BI-0252 is an orally active, selective *MDM2-p53* inhibitor with an IC₅₀ of 4 nM. BI-0252 can induce tumor regressions in all animals of a mouse SJSA-1 xenograft, with concomitant induction of the tumor protein p53 (TP53) target genes and markers of apoptosis .

HY-158039

YCH2823	Deubiquitinase Apoptosis	Cancer
YCH2823 is an inhibitor of USP7 (IC₅₀ = 49.6 nM; K_d = 0.117 μM). YCH2823 shows significant efficacy in inhibiting TP53 wild-type and mutant tumors, with approximately 5-fold higher potency than FT671. YCH2823 induce apoptosis. YCH2823 synergistic effects with mTOR inhibitors .

HY-159646

BMS-986397	Molecular Glues Ligands for E3 Ligase Casein Kinase Apoptosis	Cancer
BMS-986397 is a cereblon-based CK1α (casein kinase 1α) molecular glue degrader that can cause rapid apoptosis and cell cycle arrest in TP53 wild-type AML (acute myeloid leukemia) cells. BMS-986397 can be used for the study of AML and HR-MDS (High-Risk Myelodysplastic Syndrome) .

HY-10029

Nutlin-3a Maximum Cited Publications 58 Publications Verification Rebemadlin	MDM-2/p53 E1/E2/E3 Enzyme Autophagy Apoptosis	Cancer
Nutlin-3a (Rebemadlin), an active enantiomer of Nutlin-3, is a potent murine double minute (MDM2) inhibitor (IC₅₀=90 nM). Nutlin-3a inhibits *MDM2-p53* interactions and stabilizes the p53 protein, and induces cell autophagy and apoptosis. Nutlin-3a has the potential for the study of TP53 wild-type ovarian carcinomas .

HY-P10925

Zolucatetide FOG-001; I-66	β-catenin	Cancer
Zolucatetide (FOG-001;I-66) is a potent β-catenin inhibitor with an IC₅₀ of <50 nM. Zolucatetide can inhibits β-catenin and T-cell factor (TCF) transcription factor interaction. Zolucatetide inhibits cell proliferation and induces cell cycle arrest in target cells. Zolucatetide exhibits anti-tumor efficacy in mice bearing COLO320DM colon cancer cell (with APC, TP53 mutations) xenografts. Zolucatetide can be used for the study of colon cancer .

HY-176083

ASTX295	MDM-2/p53	Cancer
ASTX295 is a selective mouse double minute 2 (MDM2) antagonist with an IC₅₀ value of <1 nM. ASTX295 specifically blocks the interaction between MDM2 and p53, reactivating wild-type (WT) TP53, and then inducing the expression of related transcriptional targets, leading to cell death and cell cycle arrest. ASTX295 is promising for research of lymphoid malignancies, such as diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and T-cell lymphoma .

HY-P10925A

(Z)-Zolucatetide (Z)-FOG-001; I-67	β-catenin	Cancer
(Z)-Zolucatetide ((Z)-FOG-001; I-67), a structural isomer of Zolucatetide (HY-P10925), is a potent β-catenin inhibitor with an IC₅₀ of <50 nM. Zolucatetide can inhibits β-catenin and T-cell factor (TCF) transcription factor interaction. Zolucatetide inhibits cell proliferation and induces cell cycle arrest in target cells. Zolucatetide exhibits anti-tumor efficacy in mice bearing COLO320DM colon cancer cell (with APC, TP53 mutations) xenografts. Zolucatetide can be used for the study of colon cancer .

HY-P1925A

GO-203 TFA 2 Publications Verification	PI3K Reactive Oxygen Species (ROS) Apoptosis	Cancer
GO-203 TFA is a potent MUC1-C oncoprotein inhibitor. GO-203 TFA is an all D-amino acid peptide that consists of a poly-R transduction domain linked to a CQCRRKN motif that binds to the MUC1-C cytoplasmic tail and blocks MUC1-C homodimerization. GO-203 TFA downregulates TIGAR (TP53-induced glycolysis and apoptosis regulator) protein synthesis by inhibiting the PI3K-AKT-S6K1 pathway. GO-203 TFA induces the production of ROS and loss of mitochondrial transmembrane potential. GO-203 TFA inhibits the growth of colon cancer cells in vitro and as xenografts in nude mice .

HY-W181530

NCT02	Molecular Glues CDK Apoptosis Ligands for E3 Ligase	Cancer
NCT02 is a molecular glue degrader based on the E3 ubiquitin ligase DDB1 that targets CDK12 and its binding partner CCNK. NCT02 triggers the ubiquitination and proteasomal degradation of CCNK, thereby downregulating CDK12 protein levels and inhibiting its downstream signaling pathways. NCT02 can induce tumor cell apoptosis, arrest the cell cycle, and selectively inhibit the proliferation of colorectal cancer cells carrying *TP53* defects or belonging to the consensus molecular subtype CMS4. NCT02 has the potential to inhibit tumor growth in in vitro and in vivo models .

HY-148409

MMRi62	Ferroptosis Apoptosis Autophagy MDM-2/p53	Cancer
MMRi62, a ferroptosis inducer targeting MDM2-MDM4 (negative regulators of tumor suppressor p53). MMRi62 shows a P53-independent pro-apoptotic activity against pancreatic ductal adenocarcinoma (PDAC) cells and induce autophagy. MMRi62 inducesferroptosis, resulting in a increase of reactive oxygen and lysosomal degradation of ferritin heavy chain (FTH1). MMRi62 also leads to proteasomal degradation of mutant p53, also inhibits orthotopic xenograft PDAC mouse model in vivo with high frequency mutation characteristics of KRAS and TP53.12 .

HY-15898

Y-320 4 Publications Verification	Interleukin Related Apoptosis	Inflammation/Immunology Cancer
Y-320 is a potent, orally active phenylpyrazoleanilide immunomodulator. Y-320 inhibits IL-17 production by CD4 T cells stimulated with IL-15 with IC₅₀ values of 20 to 60 nM. Y-320 enhances TP53, DMD, and COL17A1 PTC readthrough by G418 and increases cellular protein levels and protein synthesis. Y-320 concomitants use of with a low dose of Paclitaxel (HY-B0015) significantly sensitized multidrug resistance (MDR) tumors by inducing G2/M phase arrest and apoptosis. Y-320 can be used for research of rheumatoid arthritis (RA) and cancer .

HY-164544

USP7-055	Deubiquitinase	Cancer
USP7-055 is a USP7 inhibitor. USP7-055 can be used in cancer research .

HY-124036

DS-7423	PI3K mTOR	Cancer
DS-7423 is a dual PI3K and mTOR inhibitor, with IC₅₀ values of 15.6 nM, 34.9 nM for PI3Kα and mTOR, respectively. DS-7423 possesses anti-tumor activity .

HY-150620

BI-0282	MDM-2/p53	Cancer
BI-0282 (Compound 1) is a potent *MDM2-p53* interaction inhibitor .

HY-P4210

Sulanemadlin ALRN-6924; MP-4897	MDM-2/p53	Cancer
Sulanemadlin (ALRN-6924) is a potent and cell-permeating p53-based peptidomimetic macrocycles. Sulanemadlin is a inhibitor of the p53-MDM2, p53-MDMX, or both p53 and MDM2 and MDMX protein-protein interactions. Sulanemadlin can be used for cancers research .

HY-RS15102

Trp53 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Trp53 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Trp53 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Trp53 Mouse Pre-designed siRNA Set A Trp53 Mouse Pre-designed siRNA Set A

Cat. No.	Product Name	Type

HY-19980G

Eprenetapopt (GMP) APR-246 (GMP); PRIMA-1Met (GMP)	Fluorescent Dye
Eprenetapopt (GMP) (APR-246(GMP)) is Eprenetapopt (HY-19980) in GMP grade. Eprenetapopt (APR-246) is a first-in-class, small molecule that restores wild-type p53 functions in TP53-mutant cells. Eprenetapopt triggers apoptosis in tumor cells. Eprenetapopt also targets the selenoprotein thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance .

Cat. No.	Product Name	Type

HY-19980G

Eprenetapopt (GMP) APR-246 (GMP); PRIMA-1Met (GMP)	Biochemical Assay Reagents
Eprenetapopt (GMP) (APR-246(GMP)) is Eprenetapopt (HY-19980) in GMP grade. Eprenetapopt (APR-246) is a first-in-class, small molecule that restores wild-type p53 functions in TP53-mutant cells. Eprenetapopt triggers apoptosis in tumor cells. Eprenetapopt also targets the selenoprotein thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance .

Cat. No.	Product Name	Target	Research Area

HY-P10925

Zolucatetide FOG-001; I-66	β-catenin	Cancer
Zolucatetide (FOG-001;I-66) is a potent β-catenin inhibitor with an IC₅₀ of <50 nM. Zolucatetide can inhibits β-catenin and T-cell factor (TCF) transcription factor interaction. Zolucatetide inhibits cell proliferation and induces cell cycle arrest in target cells. Zolucatetide exhibits anti-tumor efficacy in mice bearing COLO320DM colon cancer cell (with APC, TP53 mutations) xenografts. Zolucatetide can be used for the study of colon cancer .

HY-P1925A

GO-203 TFA 2 Publications Verification	PI3K Reactive Oxygen Species (ROS) Apoptosis	Cancer
GO-203 TFA is a potent MUC1-C oncoprotein inhibitor. GO-203 TFA is an all D-amino acid peptide that consists of a poly-R transduction domain linked to a CQCRRKN motif that binds to the MUC1-C cytoplasmic tail and blocks MUC1-C homodimerization. GO-203 TFA downregulates TIGAR (TP53-induced glycolysis and apoptosis regulator) protein synthesis by inhibiting the PI3K-AKT-S6K1 pathway. GO-203 TFA induces the production of ROS and loss of mitochondrial transmembrane potential. GO-203 TFA inhibits the growth of colon cancer cells in vitro and as xenografts in nude mice .

HY-P4210

Sulanemadlin ALRN-6924; MP-4897	MDM-2/p53	Cancer
Sulanemadlin (ALRN-6924) is a potent and cell-permeating p53-based peptidomimetic macrocycles. Sulanemadlin is a inhibitor of the p53-MDM2, p53-MDMX, or both p53 and MDM2 and MDMX protein-protein interactions. Sulanemadlin can be used for cancers research .

HY-P11089

TP53 neoepitope	MHC	Cancer
TP53 neoepitope is a high-affinity antigenic peptide targeting HLA-A. TP53 neoepitope can triggers CD8 ⁺ T cell-mediated killing of TP53-mutant tumor cells. TP53 neoepitope is promising for research of solid tumors harboring TP53 hotspot mutations (e.g., R175H, R273H) .

HY-P10925A

(Z)-Zolucatetide (Z)-FOG-001; I-67	β-catenin	Cancer
(Z)-Zolucatetide ((Z)-FOG-001; I-67), a structural isomer of Zolucatetide (HY-P10925), is a potent β-catenin inhibitor with an IC₅₀ of <50 nM. Zolucatetide can inhibits β-catenin and T-cell factor (TCF) transcription factor interaction. Zolucatetide inhibits cell proliferation and induces cell cycle arrest in target cells. Zolucatetide exhibits anti-tumor efficacy in mice bearing COLO320DM colon cancer cell (with APC, TP53 mutations) xenografts. Zolucatetide can be used for the study of colon cancer .

Species:	Human (10) Rat (1)
Tag:	His (10) SUMO (1) Avi (6) TAT (1)
Source:	HEK293 (6) E. coli (5)

Cat. No.	Compare	Product Name	Species	Source

HY-P71703

	p53 Protein, Rat (His) TP53; P53; Cellular tumor antigen p53; Tumor suppressor p53	Rat	E. coli
	The p53 protein acts as a tumor suppressor, regulates the cell cycle and induces growth arrest or apoptosis.It activates genes that inhibit cell division and trigger apoptosis by controlling the expression of various proteins.p53 Protein, Rat (His) is the recombinant rat-derived p53 protein, expressed by E.coli , with N-6*His labeled tag.

HY-P71919

	TIGAR Protein, Human (TAT) 6-bisphosphatase TIGAR; C12ORF5; chromosome 12 open reading frame 5; FR2BP; Fructose-2,6-bisphosphatase TIGAR; Fructose-2,6-bisphosphate 2-phosphatase; Probable fructose 2,6 bisphosphatase TIGAR; Probable fructose-2; tigar; TIGAR_HUMAN; TP53 induced glycolysis and apoptosis regulator; TP53 induced glycolysis regulatory phosphatase; TP53-induced glycolysis and apoptosis regulator; Transactivated by NS3TP2 protein	Human	E. coli
	TIGAR is a protein that helps cells survive stress by regulating glycolysis and promoting cell survival. It reduces reactive oxygen species (ROS) levels and protects against oxidative damage. TIGAR also plays a role in promoting tissue regeneration and has neuroprotective effects. In cancer cells, TIGAR promotes DNA repair and is involved in tumor progression. TIGAR Protein, Human (TAT) is the recombinant human-derived TIGAR protein, expressed by E. coli , with C-TAT labeled tag.

HY-P77778

	*HLA-A02:01&B2M&P53 WT(HMTEVVRRC) Monomer Protein, Human (HEK293, His-Avi)** MHC; HLA-A; P53; TP53; Antigen NY-CO-13; BCC7; FLJ92943; LFS1; TRP53	Human	HEK293

HY-P77779

	*HLA-A02:01&B2M&P53 WT(HMTEVVRRC) Monomer Protein, Human (Biotinylated, HEK293, His-Avi)** MHC; HLA-A; P53; TP53; Antigen NY-CO-13; BCC7; FLJ92943; LFS1; TRP53	Human	HEK293

HY-P77780

	*HLA-A02:01-B2M&P53 WT(HMTEVVRRC) Tetramer Protein, Human (HMTEVVRRC, HEK293, His-Avi)** MHC; HLA-A; P53; TP53; Antigen NY-CO-13; BCC7; FLJ92943; LFS1; TRP53	Human	HEK293

HY-P77775

	*HLA-A02:01&B2M&P53 R175H(HMTEVVRHC) Monomer Protein, Human (HEK293, His-Avi)** MHC; HLA-A; P53; TP53; Antigen NY-CO-13; BCC7; FLJ92943; LFS1; TRP53	Human	HEK293

HY-P77777

	*HLA-A02:01&B2M&P53 R175H(HMTEVVRHC) Tetramer Protein, Human (HEK293, His-Avi)** MHC; HLA-A; P53; TP53; Antigen NY-CO-13; BCC7; FLJ92943; LFS1; TRP53	Human	HEK293

HY-P77776

	*HLA-A02:01&B2M&P53 R175H(HMTEVVRHC) Monomer Protein, Human (Biotinylated, HEK293, His-Avi)** MHC; HLA-A; P53; TP53; Antigen NY-CO-13; BCC7; FLJ92943; LFS1; TRP53	Human	HEK293

HY-P72257

	*Cellular tumor antigen P53/TP53, Human (His-SUMO)* 1 Publications Verification BCC7; p53; p53 tumor suppressor; Phosphoprotein p5	Human	E. coli
	The cellular tumor antigen P53/TP53 is a tumor suppressor that can induce growth arrest or apoptosis in a variety of tumor types. It regulates the cell cycle by negatively controlling genes critical for division. Cellular tumor antigen P53/TP53, Human (His-SUMO) is the recombinant human-derived Cellular tumor antigen P53/TP53, expressed by E. coli , with N-SUMO, N-6*His labeled tag.

HY-P74632

	PIG3 Protein, Human (His) Quinone oxidoreductase PIG3; TP53I3; PIG3	Human	E. coli
	PIG3 is a key player in cellular processes, functioning as an enzyme that catalyzes NADPH-dependent quinone reduction. It exhibits moderate enzymatic activity towards β-naphthoquinone, with the para -quinone isomer (1,2-β-naphthoquinone) compared to the para -isomer (1,4-β-naphthoquinone). Obvious preference. PIG3 Protein, Human (His) is the recombinant human-derived PIG3 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P70417

	GAMT Protein, Human (His) rHuGuanidinoacetate N-methyltransferase/GAMT, His; Guanidinoacetate N-methyltransferase; GAMT; PIG2; TP53I2	Human	E. coli
	GAMT protein uses S-adenosylmethionine as a methyl donor to catalyze the conversion of guanidinoacetic acid into creatine, playing a key role in cell metabolism. This enzyme activity is essential for the biosynthesis of creatine, a compound necessary for cellular energy storage and transport. GAMT Protein, Human (His) is the recombinant human-derived GAMT protein, expressed by E. coli , with N-6His, C-6His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80938

	p53 Antibody TP53; P53; Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53	WB, IHC-P, IHC-F, ICC/IF, ELISA	Human, Mouse, Rat, Monkey
	p53 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to p53.

HY-P80843

	Phospho-p53 (Ser37) Antibody 1 Publications Verification TP53; P53; Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53	WB, ICC/IF	Human, Mouse, Rat
	Phospho-p53 (Ser37) Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to Phospho-p53 (Ser37).

HY-P80844

	Phospho-p53 (Ser6) Antibody (YA166) TP53; P53; Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53	WB, IHC-P, IP	Human
	Phospho-p53 (Ser6) Antibody (YA166) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-p53 (Ser6).

HY-P86652

	Phospho-p53(S15) Antibody (YA6344) TP53; P53; Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53	WB, ICC/IF	Human
	Phospho-p53(S15) Antibody (YA6344) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-p53(S15).

HY-P82831

	TP53BP2 Antibody (YA2576) 53BP2; ASPP2; p53BP2; PPP1R13A; TP53bp2	WB, IHC-P, ICC/IF	Human
	TP53BP2 Antibody (YA2576) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to TP53BP2.

HY-P86277

	TP53BP2 Antibod (YA5969) TP53BP2; ASPP2; BBP; Apoptosis-stimulating of p53 protein 2 ; Bcl2-binding protein; Bbp; Renal carcinoma antigen NY-REN-51; Tumor suppressor p53-binding protein 2; 53BP2; p53-binding protein 2; p53BP2;	WB, IHC-P, ICC/IF, ICC	Human
	TP53BP2 Antibody (YA5969) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to TP53BP2.

HY-P83948

	p53 Antibody (YA3645) LFS1, TRP53, TP53	WB, IHC-P, ELISA	Human
	p53 Antibody (YA3645) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to p53.

HY-P86169

	p53 Antibody (YA5861) Antigen NY-CO-13; BCC7; Cellular tumor antigen p53; FLJ92943; LFS1; Mutant tumor protein 53; p53; p53 tumor suppressor; P53_HUMAN; Phosphoprotein p53; TP53; Transformation related protein 53; TRP53; tumor antigen p55; Tumor protein 53; Tumor protein p53; Tumor suppressor p53;	WB, IHC-P, ICC/IF, IP, ELISA	Human
	p53 Antibody (YA5861) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to p53.

HY-P84041

	SAA1 Antibody (YA3738) SAA; PIG4; SAA2; TP53I4	IHC-P, FC, ELISA	Human
	SAA1 Antibody (YA3738) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to SAA1.

HY-P84796

	p63 Antibody (YA4493) TP63,AIS; KET; LMS; NBP; RHS; p40; p51; p63; EEC3; OFC8; p73H; p73L; SHFM4; TP53L; TP73L; p53CP; TP53CP; B(p51A); B(p51B)	IHC-P, FC, ELISA	Human
	p63 Antibody (YA4493) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to p63.

HY-P82704

	MAD1L1 Antibody (YA2449) hMAD1; HsMAD1; MAD1; MAD1L1; PIG9; TP53I9; TXBP181	WB	Human, Mouse, Rat
	MAD1L1 Antibody (YA2449) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MAD1L1.

HY-P81996

	Prostaglandin E Synthase Antibody (YA1741) PGES; MPGES; PIG12; PP102; PP1294; MGST-IV; MGST1L1; TP53I12; mPGES-1; MGST1-L1	WB	Human, Mouse, Rat
	Prostaglandin E Synthase Antibody (YA1741) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Prostaglandin E Synthase.

HY-P86435

	53BP1 Antibody (YA6127) TP53BP1; Tumor suppressor p53-binding protein 1; 53BP1; p53-binding protein 1; p53BP1	WB, ICC/IF, IP, ELISA	Human
	53BP1 Antibody (YA6127) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to 53BP1.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: